Arch Biopartners, Inc.

Established to acquire and develop early stage technology projects originating from universities.
Portfolio approach mitigates risk
Low cash burn rate and controlled overhead costs due to university relationships
Focused on sale of technology after achieving proof of commercialization
Experienced business-minded management
Large pipeline of projects from the Arch Biopartners academic network
Projects that do not progress and meet set milestones will be dropped from Arch Biopartners’ portfolio